Each vial contains 10 mg of VIP (vasoactive intestinal peptide), in lyophilized form.
VIP is a 28-amino-acid neuropeptide belonging to the secretin-glucagon peptide superfamily. It occurs endogenously in neurons of the central and peripheral nervous systems and in the gastrointestinal tract, where it functions as a neurotransmitter and neuroendocrine signalling molecule.
VIP signals principally through the G protein-coupled receptors VPAC1 and VPAC2, with lower affinity at PAC1, raising intracellular cyclic AMP. Published research examines it across three broad areas: immune regulation, smooth muscle and vascular tone, and circadian signalling, the last reflecting the role of VIP-expressing neurons in the suprachiasmatic nucleus.
Areas of published research
- VPAC1 and VPAC2 receptor binding affinity and cyclic AMP response in cell assays
- Cytokine profile shifts and regulatory T cell induction in immune and inflammatory models
- Circadian period and phase synchronisation in suprachiasmatic nucleus preparations and rodent models
- Pulmonary vascular tone and airway smooth muscle relaxation endpoints in preclinical research
- Microglial activation and neuroinflammation markers in neuroprotection models
For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.


Reviews
There are no reviews yet.